Document is current
Any future updates will be listed below
-
Authors
Li, Fan
Hu, Haiyi
Li, Liyang
Ding, Lifeng
Lu, Zeyi
Mao, Xudong
Wang, Ruyue
Luo, Wenqin
Lin, Yudong
Li, Yang
Chen, Xianjiong
Zhu, Ziwei
Lu, Yi
Zhou, Chenghao
Wang, Mingchao
Xia, Liqun
Li, Gonghui
Gao, Lei
-
Funding
Funding for this research was provided by:
Zhejiang Provincial Natural Science Foundation of China (LY22H160009)
National Natural Science Foundation of China (82072809, 82173221)
The Joint Funds of the Zhejiang Provincial Natural Science Foundation of China (LHDMZ23H160004)
Joint construction project of Zhejiang Province and Ministry (2020388200)
the “Pioneer” and “Leading Goose’ R&D Program of Zhejiang Province (2024C03045)
- License Information
-
More Information
Article History
Received: 7 October 2024
Accepted: 4 December 2024
First Online: 21 December 2024
Declarations
:
: All clinical renal cell carcinoma tissue specimens were obtained from patients at Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University. Informed consent was obtained from each participant prior to sample collection. This study adhered to the principles outlined in the Declaration of Helsinki and received approval from the Ethics Committee of Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University (No.20220317).
: The authors declare no competing interests.
